Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. M. Sandovici

Publications

18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scores

Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica:: comparison of disease characteristics and treatment requirement. Reply

Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics

Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis

Improved Diagnostic Accuracy for Polymyalgia Rheumatica using FDG-PET/CT with Clinical Diagnosis or 2012 ACR/EULAR Classification Criteria

Press/media

Vasculitis Foundation: international research insights

Alleen paardenmiddel helpt tegen spierreuma

Combinatietherapie prednison en leflunomide bij spierreuma